Cargando…
Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study
BACKGROUND: Currently there is no effective treatment available to retard cyst growth and to prevent the progression to end-stage renal failure in patients with autosomal dominant polycystic kidney disease (ADPKD). Evidence has recently been obtained from animal experiments that activation of the ma...
Autores principales: | Serra, Andreas L, Kistler, Andreas D, Poster, Diane, Struker, Marian, Wüthrich, Rudolf P, Weishaupt, Dominik, Tschirch, Frank |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central|1
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2048941/ https://www.ncbi.nlm.nih.gov/pubmed/17868472 http://dx.doi.org/10.1186/1471-2369-8-13 |
Ejemplares similares
-
Low-Dose Oral Sirolimus and the Risk of Menstrual-Cycle Disturbances and Ovarian Cysts: Analysis of the Randomized Controlled SUISSE ADPKD Trial
por: Braun, Matthias, et al.
Publicado: (2012) -
Growth of arachnoid cysts in patients with autosomal dominant polycystic kidney disease: serial imaging and clinical relevance
por: Krauer, Fabienne, et al.
Publicado: (2012) -
Long-term effect of coffee consumption on autosomal dominant polycystic kidneys disease progression: results from the Suisse ADPKD, a Prospective Longitudinal Cohort Study
por: Girardat-Rotar, Laura, et al.
Publicado: (2017) -
Urinary Proteomic Biomarkers for Diagnosis and Risk Stratification of Autosomal Dominant Polycystic Kidney Disease: A Multicentric Study
por: Kistler, Andreas D., et al.
Publicado: (2013) -
Hypertension in autosomal-dominant polycystic kidney disease (ADPKD)
por: Sans-Atxer, Laia, et al.
Publicado: (2013)